Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication <it>in vitro </it>and provide a rationale to redesign antiretroviral treatment for feline AIDS
<p>Abstract</p> <p>Background</p> <p>Treatment of feline immunodeficiency virus (FIV) infection has been hampered by the absence of a specific combination antiretroviral treatment (ART). Integrase strand transfer inhibitors (INSTIs) are emerging as a promising new drug...
Main Authors: | Ciervo Alessandra, Barreca Maria, De Luca Laura, Matteucci Donatella, Ferro Stefania, Mancini Fabiola, Taglia Fabiana, Zabogli Elisa, D'Ostilio Daniela, Pistello Mauro, Savarino Andrea, Chimirri Alba, Ciccozzi Massimo, Bendinelli Mauro |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-10-01
|
Series: | Retrovirology |
Online Access: | http://www.retrovirology.com/content/4/1/79 |
Similar Items
-
Immunotherapy with internally inactivated virus loaded dendritic cells boosts cellular immunity but does not affect feline immunodeficiency virus infection course
by: Pistello Mauro, et al.
Published: (2008-04-01) -
Feline Immunodeficiency Virus in South America
by: Bruno M. Teixeira, et al.
Published: (2012-03-01) -
Studies of the pathogenesis of feline immunodeficiency virus
by: Haining, Hayley
Published: (2004) -
Prevalence of feline immunodeficiency virus and feline leukaemia virus in domestic cats in Hungary
by: Anna Szilasi, et al.
Published: (2019-12-01) -
Correlation of feline immunodeficiency virus status and the severity of feline chronic gingivostomatitis
by: Reginaldo Pereira de Sousa Filho, et al.
Published: (2018-11-01)